Guggenheim Downgrades Icosavax to Neutral
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Seamus Fernandez has downgraded Icosavax (NASDAQ:ICVX) from Buy to Neutral, indicating a change in the firm's outlook on the stock.
January 02, 2024 | 10:33 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Icosavax has been downgraded by Guggenheim from Buy to Neutral, which may influence investors' perception and could potentially lead to a decrease in stock price in the short term.
Downgrades by analysts, such as the one from Guggenheim for Icosavax, can often lead to a negative short-term reaction in the stock market as investors adjust their expectations based on the new rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100